A carregar...
伊布替尼治疗复发/难治原发性自身免疫性溶血性贫血二例——探索性研究
OBJECTIVE: To explore the efficacy and safety of ibrutinib treatment for relapsed/refractory（R/R）primary autoimmune hemolytic anemia（AIHA）. METHODS: Two cases of primary AIHA with relapse events were refractory to glucocorticoid, anti-CD20 monoclonal antibody, immunosuppressive drugs, and splenectom...
Na minha lista:
| Publicado no: | Zhonghua Xue Ye Xue Za Zhi |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Editorial office of Chinese Journal of Hematology
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7342072/ https://ncbi.nlm.nih.gov/pubmed/32536139 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3760/cma.j.issn.0253-2727.2020.05.009 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|